Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics

OBJECTIVE: Clinical trials demonstrate improving survival in patients with multiple myeloma (MM) after treatment. However, it is unclear whether increased survival translates to a similar benefit in a real world setting. METHODS: We analyzed the overall survival of 347 multiple myeloma patients in A...

Descripción completa

Detalles Bibliográficos
Autores principales: Willenbacher, Ella, Weger, Roman, Rochau, Ursula, Siebert, Uwe, Willenbacher, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777410/
https://www.ncbi.nlm.nih.gov/pubmed/26937956
http://dx.doi.org/10.1371/journal.pone.0147381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777410/
https://www.ncbi.nlm.nih.gov/pubmed/26937956
http://dx.doi.org/10.1371/journal.pone.0147381

Ejemplares similares